Skip to content
Search

Latest Stories

Pharmacists urge Keir Starmer to appoint medicine supply Tsar to address growing shortage crisis

Pharmacists urge Keir Starmer to appoint medicine supply Tsar to address growing shortage crisis

Recent analysis by the NPA revealed that the number of SSPs issued by the Department of Health when medicine shortages are most acute has more than tripled in the past two years

Community pharmacists are calling on the new Labour government led by Keir Starmer to appoint a medicine supply Tsar to address the worsening medicine shortage crisis, as recent polling reveals that around three in ten patients have experienced difficulties obtaining medicines they need.


The National Pharmacy Association (NPA), representing independent community pharmacies, has stressed the need for a 'medicine shortages Tsar' to get a grip on the problem that has blighted both patients and pharmacies in recent years.

A YouGov survey commissioned by the NPA found that in the past year, 28 per cent of people were unable to collect a prescription from their local pharmacy due to medicine shortages.

Among those affected, 6 per cent experienced this 3-4 times, and 5 per cent encountered it five times or more in the last year alone. Of these patients, 32 per cent reported that the shortages had adversely affected their health, with 7 per cent  stating it had a 'great deal' of impact and 25 per cent noting a 'fair deal' of impact.

The NPA emphasised that the proposed Tsar would be responsible for investigating the robustness of the UK's medicine supply chain and enhancing the country's competitiveness in the global medicines market.

Further, the association noted that this role would ideally be filled by an independent expert with technical knowledge of medicine supply, capable of bringing together a wide range of industry organisations to tackle this complex problem.

Recent analysis by the NPA revealed that the number of Serious Shortage Protocols (SSPs), issued by the Department of Health when shortages are most acute, has more than tripled in the past two years. 78 per cent of all SSPs were issued between 2022 and 2024.

SSPs have been issued for a diverse range of medication treating conditions including; cystic fibrosis, angina, menopause symptoms, whooping cough, chest infections, contraception, depression, epilepsy, thyroid problems and anaphylaxis among many others.

Paul Rees, CEO of NPA, said: “These are incredibly worrying statistics which shows the current crisis in medicine supply is having a serious impact on people’s health.

“Although for some, a medicine shortage is frustrating and inconvenient, for others it can be potentially life threatening and have a drastic impact on how a patient can live their life.  We have seen this with the most recent shortages relating to Creon, which can be used to help those living with cystic fibrosis digest food.

“That is why we are urging the new government to appoint a medicine shortages Tsar to use this opportunity to bring together all bodies to tackle this growing and complex crisis once and for all.”

Due to shortages, pharmacies are often forced to spend hours sourcing alternative medications, driving up the cost of drugs.

Some pharmacists have reported to the NPA that ordering short-supply medications, including treatments for common conditions such as hay fever, can cost them 3 to 27 times more than the original price.

The pressure on community pharmacies is further exacerbated by a 40 per cent reduction in their funding, leading to the closure of 10 pharmacies per week so far this year.

“Medicine shortages heap pressure on already stretched community pharmacies, who have to pay inflated prices for medicines in short supply, spend hours trying to find supplies and sometimes face the heartbreaking situation of having to turn patients away,” Paul said.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less